Miller Fisher syndrome following Pfizer COVID-19 vaccine.

Ana AbičićIvan AdamecMario Habek

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

Patients with acute ophthalmoplegia occurring after COVID-19 vaccination should be screened for the presence of anti-GQ1b antibody. If the antibody is present, intravenous immunoglobulin should be administered as it may hasten clinical improvement.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
high dose
low dose